Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 118753
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.118753
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.118753
Table 1 Baseline demographic, clinicopathological, and surgical characteristics, n (%)
| Variable | Value |
| Age, median (IQR), years | 67 (65-73) |
| Sex | Female 4 (27); male 11 (73) |
| Smoking status | Former 6 (40); never 9 (60) |
| Tumor localization | Right colon 8 (53); left colon 1 (7); sigmoid 6 (40) |
| Preoperative T stage | T2 6 (40); T3 8 (53); T4 1 (7) |
| Preoperative N stage | N0 4 (27); N1 8 (53); N2 3 (20) |
| Surgical approach | Laparoscopic 10 (67); open 5 (33) |
| Type of resection | Hemicolectomy 9 (60); segmental 6 (40) |
| Anastomosis type | Manual 11 (73); mechanical 4 (27) |
| Operative duration, median (IQR), min | 180 (160-200) |
Table 2 Baseline laboratory and inflammatory parameters
| Variable | Median (IQR) |
| Hemoglobin (g/dL) | 11.92 (11.14-12.40) |
| White blood cell count (/µL) | 7000 (6320-8360) |
| C-reactive protein (mg/dL) | 0.70 (0.30-1.25) |
| Fibrinogen (mg/dL) | 378 (327-421) |
| Albumin (g/dL) | 4.15 (3.93-4.52) |
Table 3 Molecular marker cycle threshold values in tumor and adjacent tissue
| Marker | Median (IQR) |
| MicroRNA-21 | 19.11 (17.09-21.90) |
| U6 small nuclear RNA | 16.30 (15.60-17.46) |
| FS17 tumor tissue | 25.44 (24.20-29.22) |
| FS17 adjacent tissue | 25.10 (23.80-27.60) |
Table 4 MicroRNA-21 and FS17 tumor cycle threshold values by sex and smoking status
| Group | mean Ct ± SD | Median (min-max) | P value |
| miR-21 - female | 20.7 ± 2.77 | 20.9 (17.27-23.72) | 0.43 |
| miR-21 - male | 19.27 ± 3.21 | 18.93 (16.32-26.49) | |
| miR-21 - former smokers | 20.06 ± 3.71 | 19.29 (16.32-26.49) | 0.70 |
| miR-21 - never smokers | 19.38 ± 2.76 | 19.11 (16.33-23.72) | |
| FS17 tumor - female | 26.96 ± 3.99 | 25.56 (24.09-32.65) | 0.99 |
| FS17 tumor - male | 26.97 ± 3.69 | 25.44 (23.10-34.31) | |
| FS17 tumor - former smokers | 26.88 ± 4.33 | 24.96 (23.10-32.65) | 0.94 |
| FS17 tumor - never smokers | 27.03 ± 3.35 | 25.96 (24.09-34.31) |
Table 5 FS17 tumor cycle threshold values by preoperative tumor and nodal stage
| Stage | mean Ct ± SD | Median (min-max) | P value |
| T2 | 24.63 ± 1.45 | 24.20 (23.10-26.80) | 0.01 |
| T3-T4 | 28.53 ± 3.85 | 29.03 (24.20-34.31) | |
| N0 | 24.34 ± 1.19 | 24.14 (23.10-25.96) | 0.20 |
| N1 | 27.51 ± 3.98 | 26.06 (23.52-34.31) | |
| N2 | 29.04 ± 3.61 | 29.03 (25.44-32.65) |
- Citation: Turcu S, Prasoula KL, Legaki E, Grama FA, Mandi DM, Bordea A, Dutei CA, Gazouli M. Stage-dependent and heterogeneous tumor association of Fusobacterium nucleatum in Romanian patients with colon adenocarcinoma. World J Gastrointest Oncol 2026; 18(6): 118753
- URL: https://www.wjgnet.com/1948-5204/full/v18/i6/118753.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i6.118753